Literature DB >> 28093676

Aryl hydrocarbon receptor signaling involved in the invasiveness of LNCaP cells.

Hisamitsu Ide1, Yan Lu1, Jingsong Yu2, Takahiro Noguchi1, Mayuko Kanayama3, Satoru Muto1, Raizo Yamaguchi1, Suguru Kawato1,3, Shigeo Horie4.   

Abstract

There is now mounting evidence that the aryl hydrocarbon receptor (AhR) plays an important role in physiologic responses such as development, cell cycle regulation, immune function and also malignant transformation in various tissues. The strong nuclear AhR expression is observed in the invasive phenotype, and an elevated nuclear AhR expression is associated with a poor prognosis of human prostate cancer. On the other hand, there are conflicting results that the AhR deficiency results in increased susceptibility to prostate tumors in mouse model. In the present study, we investigated AhR expression and its role in the growth and invasiveness of human prostate cancer cells. The AhR protein expression was detected in prostate cancer cell lines and human prostate cancer tissues. A small interfering RNA targeting AhR, constitutive active AhR expression vector, and AhR agonist and antagonist were used to moderate its expression and signaling. The induction of AhR signaling attenuated invasiveness of prostate cancer cells without affecting the cellular growth rate. These results suggest that AhR signaling in prostate cancer cells facilitates invasion of these cells, and modulation with this signaling can be a potential therapeutic target of invasive tumors.

Entities:  

Keywords:  Aryl hydrocarbon receptor; Invasion; Prostate cancer

Mesh:

Substances:

Year:  2017        PMID: 28093676     DOI: 10.1007/s13577-016-0158-2

Source DB:  PubMed          Journal:  Hum Cell        ISSN: 0914-7470            Impact factor:   4.174


  21 in total

Review 1.  Aryl hydrocarbon receptor ligands in cancer: friend and foe.

Authors:  Iain A Murray; Andrew D Patterson; Gary H Perdew
Journal:  Nat Rev Cancer       Date:  2014-12       Impact factor: 60.716

Review 2.  Aryl hydrocarbon receptor, cell cycle regulation, toxicity, and tumorigenesis.

Authors:  Jennifer L Marlowe; Alvaro Puga
Journal:  J Cell Biochem       Date:  2005-12-15       Impact factor: 4.429

3.  Activation of the dioxin/aryl hydrocarbon receptor (AhR) modulates cell plasticity through a JNK-dependent mechanism.

Authors:  M Diry; C Tomkiewicz; C Koehle; X Coumoul; K Walter Bock; R Barouki; C Transy
Journal:  Oncogene       Date:  2006-04-17       Impact factor: 9.867

4.  Modeling of the aryl hydrocarbon receptor (AhR) ligand binding domain and its utility in virtual ligand screening to predict new AhR ligands.

Authors:  William H Bisson; Daniel C Koch; Edmond F O'Donnell; Sammy M Khalil; Nancy I Kerkvliet; Robert L Tanguay; Ruben Abagyan; Siva Kumar Kolluri
Journal:  J Med Chem       Date:  2009-09-24       Impact factor: 7.446

5.  Aryl hydrocarbon receptor gene silencing with small inhibitory RNA differentially modulates Ah-responsiveness in MCF-7 and HepG2 cancer cells.

Authors:  Maen Abdelrahim; Roger Smith; Stephen Safe
Journal:  Mol Pharmacol       Date:  2003-06       Impact factor: 4.436

6.  Disruption of cell-cell contact maximally but transiently activates AhR-mediated transcription in 10T1/2 fibroblasts.

Authors:  Young C Cho; Wenchao Zheng; Colin R Jefcoate
Journal:  Toxicol Appl Pharmacol       Date:  2004-09-15       Impact factor: 4.219

7.  Characterization of the activated form of the aryl hydrocarbon receptor in the nucleus of HeLa cells in the absence of exogenous ligand.

Authors:  S S Singh; N G Hord; G H Perdew
Journal:  Arch Biochem Biophys       Date:  1996-05-01       Impact factor: 4.013

8.  Aryl hydrocarbon receptor pathway activation enhances gastric cancer cell invasiveness likely through a c-Jun-dependent induction of matrix metalloproteinase-9.

Authors:  Tie-Li Peng; Jie Chen; Wei Mao; Xin Song; Min-Hu Chen
Journal:  BMC Cell Biol       Date:  2009-04-16       Impact factor: 4.241

9.  The aryl hydrocarbon receptor is constitutively active in advanced prostate cancer cells.

Authors:  Oliver Richmond; Maryam Ghotbaddini; Cidney Allen; Alice Walker; Shokouh Zahir; Joann B Powell
Journal:  PLoS One       Date:  2014-04-22       Impact factor: 3.240

10.  The aryl hydrocarbon receptor ligand omeprazole inhibits breast cancer cell invasion and metastasis.

Authors:  Un-Ho Jin; Syng-Ook Lee; Catherine Pfent; Stephen Safe
Journal:  BMC Cancer       Date:  2014-07-09       Impact factor: 4.430

View more
  3 in total

1.  Inhibition of the aryl hydrocarbon receptor/polyamine biosynthesis axis suppresses multiple myeloma.

Authors:  Anna Bianchi-Smiraglia; Archis Bagati; Emily E Fink; Hayley C Affronti; Brittany C Lipchick; Sudha Moparthy; Mark D Long; Spencer R Rosario; Shivana M Lightman; Kalyana Moparthy; David W Wolff; Dong Hyun Yun; Zhannan Han; Anthony Polechetti; Matthew V Roll; Ilya I Gitlin; Katerina I Leonova; Aryn M Rowsam; Eugene S Kandel; Andrei V Gudkov; P Leif Bergsagel; Kelvin P Lee; Dominic J Smiraglia; Mikhail A Nikiforov
Journal:  J Clin Invest       Date:  2018-09-10       Impact factor: 14.808

Review 2.  The Kynurenine Pathway and Cancer: Why Keep It Simple When You Can Make It Complicated.

Authors:  Roumaïssa Gouasmi; Carole Ferraro-Peyret; Stéphane Nancey; Isabelle Coste; Toufic Renno; Cédric Chaveroux; Nicolas Aznar; Stéphane Ansieau
Journal:  Cancers (Basel)       Date:  2022-06-04       Impact factor: 6.575

Review 3.  How the AHR Became Important in Cancer: The Role of Chronically Active AHR in Cancer Aggression.

Authors:  Zhongyan Wang; Megan Snyder; Jessica E Kenison; Kangkang Yang; Brian Lara; Emily Lydell; Kawtar Bennani; Olga Novikov; Anthony Federico; Stefano Monti; David H Sherr
Journal:  Int J Mol Sci       Date:  2020-12-31       Impact factor: 6.208

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.